D Stürchler

1.5k total citations
70 papers, 1.0k citations indexed

About

D Stürchler is a scholar working on Public Health, Environmental and Occupational Health, Parasitology and Infectious Diseases. According to data from OpenAlex, D Stürchler has authored 70 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Public Health, Environmental and Occupational Health, 18 papers in Parasitology and 13 papers in Infectious Diseases. Recurrent topics in D Stürchler's work include Malaria Research and Control (30 papers), Mosquito-borne diseases and control (13 papers) and Travel-related health issues (9 papers). D Stürchler is often cited by papers focused on Malaria Research and Control (30 papers), Mosquito-borne diseases and control (13 papers) and Travel-related health issues (9 papers). D Stürchler collaborates with scholars based in Switzerland, United States and Thailand. D Stürchler's co-authors include M Just, Bruno Gottstein, Robert Steffen, Robin F. Anders, C M Rzepczyk, B. Takács, A Hanck, Allan Saul, A Degrémont and Howard M. Etlinger and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

D Stürchler

67 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Stürchler Switzerland 17 534 242 201 198 121 70 1.0k
O Doumbo Mali 22 552 1.0× 357 1.5× 140 0.7× 186 0.9× 139 1.1× 72 1.3k
Jacqueline Cattani United States 18 672 1.3× 161 0.7× 343 1.7× 119 0.6× 88 0.7× 32 1.2k
Gisely Cardoso de Melo Brazil 25 796 1.5× 237 1.0× 140 0.7× 238 1.2× 156 1.3× 84 1.3k
Martin Danis France 25 993 1.9× 566 2.3× 155 0.8× 357 1.8× 330 2.7× 57 1.8k
Caterina Guinovart Spain 21 754 1.4× 124 0.5× 141 0.7× 106 0.5× 90 0.7× 36 1.1k
Regina Joice Cordy United States 15 594 1.1× 124 0.5× 362 1.8× 114 0.6× 75 0.6× 25 1.1k
Olusola Ojurongbe Nigeria 20 515 1.0× 343 1.4× 94 0.5× 200 1.0× 188 1.6× 83 1.1k
Devendra Bansal Qatar 21 373 0.7× 273 1.1× 202 1.0× 449 2.3× 266 2.2× 70 1.3k
Rajeev K. Mehlotra United States 19 744 1.4× 285 1.2× 214 1.1× 427 2.2× 150 1.2× 50 1.5k
Nathalie Wurtz France 17 664 1.2× 171 0.7× 197 1.0× 493 2.5× 150 1.2× 42 1.2k

Countries citing papers authored by D Stürchler

Since Specialization
Citations

This map shows the geographic impact of D Stürchler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Stürchler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Stürchler more than expected).

Fields of papers citing papers by D Stürchler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Stürchler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Stürchler. The network helps show where D Stürchler may publish in the future.

Co-authorship network of co-authors of D Stürchler

This figure shows the co-authorship network connecting the top 25 collaborators of D Stürchler. A scholar is included among the top collaborators of D Stürchler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Stürchler. D Stürchler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stürchler, D. (2019). Ex oriente lux – Light comes from the east-and so does Orienta tsutsugamushi?. Travel Medicine and Infectious Disease. 30. 146–146. 2 indexed citations
2.
Stürchler, D. (2019). Escherichia coli, a threat for babies, burgers and travelers. Travel Medicine and Infectious Disease. 27. 139–139. 1 indexed citations
3.
Stürchler, D. (2016). Klebsiella and Klebs the person behind the name. Travel Medicine and Infectious Disease. 14(6). 654–654. 2 indexed citations
4.
Paget, W J, Reinhard Zbinden, Marcel Zwahlen, et al.. (2002). National Laboratory Reports of Chlamydia trachomatis Seriously Underestimate the Frequency of Genital Chlamydial Infections Among Women in Switzerland. Sexually Transmitted Diseases. 29(11). 715–720. 18 indexed citations
5.
Wall, Michael A., et al.. (1997). Tolerability and Effectiveness of Malaria Chemoprophylaxis with Mefloquine or Chloroquine with or without Co-medication. Journal of Travel Medicine. 4(3). 121–127. 9 indexed citations
6.
Wall, Michael A., et al.. (1996). Malaria Prophylaxis in Different Age Groups. Journal of Travel Medicine. 3(4). 219–223. 11 indexed citations
7.
Radloff, Paul, et al.. (1996). Arteflene Compared with Mefloquine for Treating Plasmodium falciparum Malaria in Children. American Journal of Tropical Medicine and Hygiene. 55(3). 259–262. 26 indexed citations
8.
Stürchler, D, M Just, Allan Saul, et al.. (1995). Safety, Immunogenicity, and Pilot Efficacy of Plasmodium falciparum Sporozoite and Asexual Blood-Stage Combination Vaccine in Swiss Adults. American Journal of Tropical Medicine and Hygiene. 53(4). 423–431. 43 indexed citations
9.
Peters, W., et al.. (1995). The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers. Annals of Tropical Medicine and Parasitology. 89(5). 465–468. 11 indexed citations
10.
Guiguemdé, Robert Tinga, et al.. (1994). Ro 42-1611 in the treatment of patients with mild malaria: a clinical trial in Nigeria and Burkina Faso.. PubMed. 45(3). 284–7. 19 indexed citations
11.
Stürchler, D, et al.. (1994). Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in Cameroon.. PubMed. 45(3). 288–91. 9 indexed citations
12.
Eamsila, Chirapa, et al.. (1993). Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.. PubMed. 24(4). 672–6. 6 indexed citations
13.
Stürchler, D, et al.. (1993). [Emergency treatment of malaria during travel].. PubMed. 82(35). 938–40.
14.
Stürchler, D, et al.. (1993). How Frequent are Notified Severe Cutaneous Adverse Reactions to Fansidar®?. Drug Safety. 8(2). 160–168. 23 indexed citations
15.
DuPont, Herbert L., et al.. (1993). Treatment of travellers' diarrhoea with fleroxacin: a case study. Journal of Antimicrobial Chemotherapy. 31(5). 767–776. 12 indexed citations
16.
Bunnag, D, S Chittamas, T Harinasuta, et al.. (1992). Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.. PubMed. 23(4). 777–82. 14 indexed citations
17.
Stürchler, D, Gert Zimmer, Rachel P. Berger, et al.. (1990). Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks.. Europe PMC (PubMed Central). 68 Suppl. 38–41. 5 indexed citations
18.
Stürchler, D, et al.. (1990). Malaria and mosquitoes: how often for how long?. Transactions of the Royal Society of Tropical Medicine and Hygiene. 84(6). 780–780. 2 indexed citations
19.
Stürchler, D, R. Berger, H. Etlinger, et al.. (1989). Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults. Vaccine. 7(5). 457–461. 22 indexed citations
20.
Etlinger, Howard M., A. Felix, Dieter Gillessen, et al.. (1988). Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum .. The Journal of Immunology. 140(2). 626–633. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026